MTOR and bladder transitional cell carcinoma: It is reasonable to think that the down expression of miR-100 that we previously observed in low-grade, non-invasive bladder urothelial cancer is related to the lack of control of mTOR and FGFR3 and to the maintenance of genomic stability due to not interfering with SMARCA5.